You are here

Article Text

Article menu
Download PDFPDF
Scientific report
Clinical science - Scientific reports
Vitreoretinal surgery using bromphenol blue as a vital stain: evaluation of staining characteristics in humans
  1. Christos Haritoglou,
  2. Ricarda G Schumann,
  3. Rupert Strauss,
  4. Siegfried G Priglinger,
  5. Aljoscha S Neubauer,
  6. Anselm Kampik
  1. Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany
  1. Christos Haritoglou, MD, Department of Ophthalmology, Ludwig-Maximilians-University, Mathildenstr. 8, 80336 Munich, Germany; christos.haritoglou{at}med.uni-muenchen.de

Abstract

Objective: To evaluate the staining characteristics of bromphenol blue used during vitreoretinal surgery in humans.

Patients and methods: 13 patients with epiretinal membranes were included. Before and after surgery a complete clinical examination including best corrected visual acuity, funduscopy, fluorescein angiography, OCT (Stratus), Goldmann perimetry and multifocal ERG as well as photography of the macular area was performed. Bromphenol blue was used in concentrations of 0.2% in most patients. Removed epiretinal tissue was evaluated using electron microscopy.

Results: Using dye concentrations of 0.2% a good demarcation of epiretinal membranes was seen in 11/13 patients. Staining of vitreous remnants at the vitreous base was seen in all patients. No dye-related adverse events were seen during follow-up in the functional tests (VA, ERG, perimetry) performed. Histological evaluation of epiretinal membranes showed unremarkable aspects of epiretinal cellular layers and unremarkable retinal surface of the internal limiting membrane (ILM).

Conclusion: Bromphenol blue appears to be a very helpful and safe tool in posterior segment surgery. The staining characteristics need to be further evaluated in prospective study settings and larger numbers of patients.

https://doi.org/10.1136/bjo.2007.115113

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Funding: This study was supported by a grant of the editorial board of the Münchener Medizinische Wochenschrift (MMW).

    • Competing interests: None declared.

    • Presented at the Combined meeting Club Jules Gonin/Retina Society 2006, Capetown

    • Dr Haritoglou applied for a patent for the dye and its use.

    • Abbreviations:
      ERM

      epiretinal membranes

      ICG

      indocyanine green

      ILM

      internal limiting membrane

      VA

      visual acuity

    Linked Articles